This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Humana (HUM) Boosts Value-Based Care With New PCF Model
by Zacks Equity Research
Humana (HUM) enhances its value-based healthcare model to ease the financial pressure on members and add to its capabilities.
Humana (HUM) Ties Up to Boost Presence Across West Virginia
by Zacks Equity Research
Humana (HUM) partners with St. Mary's Medical Center, which intends to offer improved health outcomes across West Virginia.
Humana (HUM) to Buy Remaining iCare Shares to Expand Medicare
by Zacks Equity Research
Humana (HUM) to acquire rest of iCare's shares from CFI to extend its Medicare business in Wisconsin.
Humana (HUM), St. Luke's Health Tie Up for Enhanced Healthcare
by Zacks Equity Research
Humana (HUM) teams up with St. Luke's Health Partners to provide better medical care in Idaho.
Humana (HUM) Down 10.2% Since Last Earnings Report: Can It Rebound?
by Zacks Equity Research
Humana (HUM) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
UnitedHealth's (UNH) Solid Earnings View Buoys Investor Hopes
by Zacks Equity Research
UnitedHealth (UNH) provides an upbeat earnings guidance for 2020 and 2021, prompted by strong growth in its UnitedHealthcare and Optum segments.
Cigna (CI) Expands Presence on Exchanges in North Carolina (Revised)
by Zacks Equity Research
Cigna (CI) expands ACA offering in additional counties across North Carolina with enhanced benefits.
Cigna (CI) Extends Medicare Advantage in North Carolina
by Sapna Bagaria
Cigna (CI) is providing Medicare Advantage business in 63 new counties within the state of North Carolina.
Humana (HUM) Enhances Value-Based Care With Vancouver Clinic
by Zacks Equity Research
Humana (HUM) intends to strengthen value-based relationship with Vancouver Clinic, which is likely to offer improved health outcomes across Clark County.
Humana (HUM) Enhances Its Services in Washington Counties
by Zacks Equity Research
Humana (HUM) recently adds to its services in Washington. Eligible members in Benton, Walla Walla and Franklin counties will now get more healthcare options.
Humana (HUM) Joins Envision for Better Healthcare in Florida
by Zacks Equity Research
Humana (HUM) expands partnership with Envision Healthcare to provide in-network medical care to its commercial, Medicare and Medicaid members in Florida.
Humana (HUM) to Offer MA Plans in Massachusetts for First Time
by Zacks Equity Research
Humana's (HUM) Medicare Advantage plans to make a debut in Massachusetts for fortifying the company's foothold in the state.
Humana (HUM) Inks Deal to Better Serve Members in Kansas Area
by Zacks Equity Research
Humana (HUM) partners Prime Healthcare to mete out better healthcare facilities to members residing in the Kansas region.
Centene (CNC) Acquires Apixio, Boosts Data Analytics Portfolio
by Zacks Equity Research
Centene (CNC) inks deal to acquire Apixio for availing enhanced AI technology solutions and digitizing its administrative activities.
Humana (HUM), Northwell Tie Up for Better Health Outcome
by Zacks Equity Research
Humana (HUM) partners with Northwell to provide improved healthcare services in the New York metropolitan region.
Cigna (CI) Rides on a Diversified Business, Capital Position
by Zacks Equity Research
Cigna's (CI) prolific business profile and a solid balance sheet position poise it well for long-term growth.
Cigna (CI) Q3 Earnings & Revenues Beat Estimates, Grow Y/Y
by Zacks Equity Research
Cigna's (CI) Q3 results reflect a strong fundamental performance across its businesses besides the return of medical utilization to more typical levels and COVID-19-related adversities.
Company News for Nov 4, 2020
by Zacks Equity Research
Companies In The News Are: W, HUM, MCK, CRUS
Humana's (HUM) Q3 Earnings Surpass Estimates, Decline Y/Y
by Zacks Equity Research
Humana's (HUM) third-quarter earnings reflect improved revenues, partly offset by expenses.
Earnings Data Deluge
by Zacks Equity Research
Earnings Data Deluge
Big Q3 Earnings Beats on Election Day: W, JELD, HUM & More
by Mark Vickery
While Fox Corp. (FOXA), Humana (HUM) and JELD-WEN (JELD) beat estimates, Wayfair (W) crushed its year-over-year earnings.
Humana (HUM) Beats Q3 Earnings and Revenue Estimates
by Zacks Equity Research
Humana (HUM) delivered earnings and revenue surprises of 7.69% and 7.50%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?
Acadia Healthcare (ACHC) Hits Fresh High: Is There Still Room to Run?
by Zacks Equity Research
Acadia Healthcare (ACHC) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Why Earnings Season Could Be Great for Humana (HUM)
by Zacks Equity Research
Humana (HUM) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Humana (HUM) Gears Up for Q3 Earnings: What Awaits the Stock?
by Zacks Equity Research
Humana's (HUM) third-quarter 2020 results are likely to reflect elevated expenses and lower net investment income, partially offset by a growing membership base.